Radical Prostatectomy as a First-Line Treatment in Patients with Initial PSA  >20 ng/mL

Table 2

Neoadjuvant and adjuvant treatment modalities.

Parameter	Group A; (𝑛=131)	Group B; (𝑛=74)	𝑃 value
Neoadjuvant hormonal therapy (𝑛/%/)	38 (29.0%)	33 (44.6%)	0.025
Adjuvant radiotherapy (ART) (𝑛/%/)	21 (16.0%)	27 (36.5%)	0.001
Adjuvant hormonal therapy (ADT) (𝑛/%/)	29 (22.1%)	29 (39.2%)	0.010
Adjuvant combined (ART & ADT) therapy (𝑛/%/)	13 (9.9%)	17 (23.0%)	0.012